Genicell technology aims to expedite and lower the cost of drug development by reducing the time and money spent bringing drugs to market. It does this by providing a more effective way to test novel drug compounds during preclinical trials, which could filter out 98% of compounds that typically fail at this stage. This approach seeks to both shorten the drug development timeline from 10-12 years as well as lower the nearly $1 billion average cost per approved drug.